This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Walking Fish Therapeutics. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Mark Selby: Innovator in Genetic Engineering
Introduction
Mark Selby is a prominent inventor based in South San Francisco, CA. He has made significant contributions to the field of genetic engineering, particularly in the development of modified B cells for therapeutic applications. His innovative work aims to address various diseases and disorders, showcasing the potential of genetic modifications in medicine.
Latest Patents
Mark Selby holds a patent for "Modified B cells and methods of use thereof." This invention relates to genetically modified B cells, which can be utilized for the treatment of a range of diseases, including cancer, heart disease, and neurological disorders. The patent describes an isolated modified B cell, known as a CAR-B cell, which expresses a chimeric receptor. This receptor is designed to enhance the therapeutic capabilities of B cells by enabling them to secrete specific payloads, such as antibodies, that are not naturally produced or are produced at higher levels than usual.
Career Highlights
Mark Selby is currently associated with Walking Fish Therapeutics, where he continues to advance his research in genetic modifications. His work is pivotal in exploring new avenues for treating complex diseases through innovative cellular therapies. With a focus on practical applications, Selby's contributions are shaping the future of medical treatments.
Collaborations
Mark collaborates with notable colleagues, including Hangil Park and Thomas Brennan. Their combined expertise fosters a dynamic research environment that enhances the development of groundbreaking therapies.
Conclusion
Mark Selby's innovative work in the field of genetic engineering exemplifies the potential of modified B cells in treating various diseases. His contributions are paving the way for future advancements in medical science.